Advertisement
Research Article

Neuropathic Pain and Psychological Morbidity in Patients with Treated Leprosy: A Cross-Sectional Prevalence Study in Mumbai

  • Estrella Lasry-Levy,

    Affiliation: London School of Hygiene & Tropical Medicine, London, United Kingdom

    X
  • Aki Hietaharju,

    Affiliation: Department of Neurology, Tampere University Hospital, Tampere, Finland

    X
  • Vivek Pai,

    Affiliation: Bombay Leprosy Project, Sion Chunabhatti, Mumbai, India

    X
  • Ramaswamy Ganapati,

    Affiliation: Bombay Leprosy Project, Sion Chunabhatti, Mumbai, India

    X
  • Andrew S. C. Rice,

    Affiliation: Department of Anaesthetics, Pain Medicine & Intensive Care, Faculty of Medicine, Imperial College, London, United Kingdom

    X
  • Maija Haanpää,

    Affiliations: Department of Neurosurgery, Helsinki University Hospital, Helsinki, Finland, ORTON Rehabilitation, Helsinki, Finland

    X
  • Diana N. J. Lockwood mail

    Diana.Lockwood@lshtm.ac.uk

    Affiliation: London School of Hygiene & Tropical Medicine, London, United Kingdom

    X
  • Published: March 08, 2011
  • DOI: 10.1371/journal.pntd.0000981
  • Featured in PLOS Collections

Reader Comments (2)

Post a new comment on this article

Thalidomide neuropathy

Posted by CRAWFIE on 11 Jun 2012 at 12:38 GMT

There has been no response to my comment posted on December 15, 2011. The authors have not carried out a nerve biopsy, thus failing to exclude thalidomide neuropathy in leprosy patients with neuropathic pain. Thalidomide must therefore be withdrawn and no longer used in the management of erythema nodosum leprosum. Alternative treatments are available to manage this complication

No competing interests declared.